S. Rosen, B. Castleman, and A. Liebow, Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.258, issue.23, pp.1123-1165, 1958.
DOI : 10.1056/NEJM195806052582301

E. Briens, P. Delaval, M. Mairesse, D. Valeyre, B. Wallaert et al., [pulmonary alveolar proteinosis], Rev Mal Respir, vol.19, pp.166-82, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01085907

R. Borie, C. Danel, M. Debray, C. Taille, M. Dombret et al., Pulmonary alveolar proteinosis, European Respiratory Review, vol.20, issue.120, pp.98-107, 2011.
DOI : 10.1183/09059180.00001311

H. Asamoto, M. Kitaichi, K. Nishimura, H. Itoh, and T. Izumi, [primary pulmonary alveolar proteinosis--clinical observation of 68 patients in japan], Nihon Kyobu Shikkan Gakkai Zasshi, vol.33, pp.835-880, 1995.

L. Goldstein, M. Kavuru, P. Curtis-mccarthy, H. Christie, C. Farver et al., Pulmonary Alveolar Proteinosis, Chest, vol.114, issue.5, pp.1357-62, 1998.
DOI : 10.1378/chest.114.5.1357

R. Larson and R. Gordinier, Pulmonary Alveolar Proteinosis, Annals of Internal Medicine, vol.62, issue.2, pp.292-312, 1965.
DOI : 10.7326/0003-4819-62-2-292

U. Prakash, S. Barham, H. Carpenter, D. Dines, and H. Marsh, Pulmonary Alveolar Phospholipoproteinosis: Experience With 34 Cases and a Review, Mayo Clinic Proceedings, vol.62, issue.6, pp.499-518, 1987.
DOI : 10.1016/S0025-6196(12)65477-9

S. Rosen, Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.258, issue.23, pp.1507-1522, 1960.
DOI : 10.1056/NEJM195806052582301

J. Seymour and J. Presneill, Pulmonary Alveolar Proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.2, pp.215-250, 2002.
DOI : 10.1164/rccm.2109105

F. Bonella, P. Bauer, M. Griese, S. Ohshimo, J. Guzman et al., Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients, Respiratory Medicine, vol.105, issue.12, pp.1908-1924, 2011.
DOI : 10.1016/j.rmed.2011.08.018

J. Whitsett, S. Wert, and T. Weaver, Alveolar Surfactant Homeostasis and the Pathogenesis of Pulmonary Disease, Annual Review of Medicine, vol.61, issue.1, pp.105-124, 2010.
DOI : 10.1146/annurev.med.60.041807.123500

S. Jouneau and Y. Uzunhan, La lipoprot??inose alv??olaire (LPA) en 2008, Revue des Maladies Respiratoires, vol.25, pp.114-134, 2008.
DOI : 10.1016/S0761-8425(08)74089-0

E. Stanley, G. Lieschke, D. Grail, D. Metcalf, G. Hodgson et al., Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology., Proceedings of the National Academy of Sciences, vol.91, issue.12, pp.5592-5598, 1994.
DOI : 10.1073/pnas.91.12.5592

Y. Shibata, P. Berclaz, Z. Chroneos, M. Yoshida, J. Whitsett et al., GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1, Immunity, vol.15, issue.4, pp.557-67, 2001.
DOI : 10.1016/S1074-7613(01)00218-7

B. Trapnell, J. Whitsett, and K. Nakata, Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.349, issue.26, pp.2527-2566, 2003.
DOI : 10.1056/NEJMra023226

T. Sakagami, K. Uchida, T. Suzuki, B. Carey, R. Wood et al., Human GM-CSF Autoantibodies and Reproduction of Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.361, issue.27, pp.2679-81, 2009.
DOI : 10.1056/NEJMc0904077

A. Malur, A. Baker, A. Mccoy, G. Wells, B. Barna et al., Restoration of PPAR?? reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice, AJP: Lung Cellular and Molecular Physiology, vol.300, issue.1, pp.73-80, 2011.
DOI : 10.1152/ajplung.00128.2010

K. Uchida, D. Beck, T. Yamamoto, P. Berclaz, S. Abe et al., GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.356, issue.6, pp.567-79, 2007.
DOI : 10.1056/NEJMoa062505

B. Wang, E. Stern, R. Schmidt, and D. Pierson, Diagnosing Pulmonary Alveolar Proteinosis, Chest, vol.111, issue.2, pp.460-466, 1997.
DOI : 10.1378/chest.111.2.460

D. Hansell, A. Bankier, H. Macmahon, T. Mcloud, N. Muller et al., Fleischner Society: Glossary of Terms for Thoracic Imaging, Radiology, vol.246, issue.3, pp.697-722, 2008.
DOI : 10.1148/radiol.2462070712

S. Rossi, J. Erasmus, M. Volpacchio, T. Franquet, T. Castiglioni et al., ???Crazy-Paving??? Pattern at Thin-Section CT of the Lungs: Radiologic-Pathologic Overview, RadioGraphics, vol.23, issue.6, pp.1509-1528, 2003.
DOI : 10.1148/rg.236035101

J. Ramirez, W. Nyka, and L. Mc, Pulmonary Alveolar Proteinosis, New England Journal of Medicine, vol.268, issue.4, pp.165-71, 1963.
DOI : 10.1056/NEJM196301242680401

K. Uchida, K. Nakata, B. Trapnell, T. Terakawa, E. Hamano et al., High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis, Blood, vol.103, issue.3, pp.1089-98, 2004.
DOI : 10.1182/blood-2003-05-1565

K. Uchida, K. Nakata, B. Carey, C. Chalk, T. Suzuki et al., Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis, Journal of Immunological Methods, vol.402, issue.1-2, pp.57-70, 2014.
DOI : 10.1016/j.jim.2013.11.011

I. Ben-dov and M. Segel, Autoimmune pulmonary alveolar proteinosis: Clinical course and diagnostic criteria, Autoimmunity Reviews, vol.13, issue.4-5, 2014.
DOI : 10.1016/j.autrev.2014.01.046

T. Bonfield, M. Kavuru, and M. Thomassen, Anti-GM-CSF Titer Predicts Response to GM-CSF Therapy in Pulmonary Alveolar Proteinosis, Clinical Immunology, vol.105, issue.3, pp.342-50, 2002.
DOI : 10.1006/clim.2002.5301

M. Kavuru, A. Malur, I. Marshall, B. Barna, M. Meziane et al., An open-label trial of rituximab therapy in pulmonary alveolar proteinosis, European Respiratory Journal, vol.38, issue.6, pp.1361-1368, 2011.
DOI : 10.1183/09031936.00197710

F. Lin, G. Chang, M. Chern, Y. Chen, and S. Chang, Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis, Thorax, vol.61, issue.6, pp.528-562, 2006.
DOI : 10.1136/thx.2005.054171

T. Kitamura, K. Uchida, N. Tanaka, T. Tsuchiya, J. Watanabe et al., Serological Diagnosis of Idiopathic Pulmonary Alveolar Proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.2, pp.658-62, 2000.
DOI : 10.1164/ajrccm.162.2.9910032

K. Uchida, K. Nakata, T. Suzuki, M. Luisetti, M. Watanabe et al., Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects, Blood, vol.113, issue.11, pp.2547-56, 2009.
DOI : 10.1182/blood-2008-05-155689

S. Leth, E. Bendstrup, H. Vestergaard, and O. Hilberg, Autoimmune pulmonary alveolar proteinosis: Treatment options in year 2013, Respirology, vol.26, issue.1, pp.82-91, 2013.
DOI : 10.1111/j.1440-1843.2012.02274.x

K. Lee, D. Levin, W. Webb, D. Chen, M. Storto et al., Pulmonary Alveolar Proteinosis, Chest, vol.111, issue.4, pp.989-95, 1997.
DOI : 10.1378/chest.111.4.989

A. Punatar, S. Kusne, J. Blair, M. Seville, and H. Vikram, Opportunistic infections in patients with pulmonary alveolar proteinosis, Journal of Infection, vol.65, issue.2, pp.173-182, 2012.
DOI : 10.1016/j.jinf.2012.03.020

M. Luisetti, P. Bruno, Z. Kadija, T. Suzuki, S. Raffa et al., Relationship Between Diffuse Pulmonary Fibrosis, Alveolar Proteinosis, and Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies, Respiratory Care, vol.56, issue.10, pp.1608-1618, 2011.
DOI : 10.4187/respcare.01054

S. Marchand-adam, B. Diot, P. Magro, D. Muret, A. Guignabert et al., Pulmonary Alveolar Proteinosis Revealing a Telomerase Disease, American Journal of Respiratory and Critical Care Medicine, vol.188, issue.3, pp.402-406, 2013.
DOI : 10.1164/rccm.201301-0010LE

J. Ramirez and G. Campbell, Pulmonary Alveolar Proteinosis, Annals of Internal Medicine, vol.63, issue.3, pp.429-470, 1965.
DOI : 10.7326/0003-4819-63-3-429

J. Ramirez, R. Kieffer, J. Ball, W. , and J. , Bronchopulmonary Lavage in Man, Annals of Internal Medicine, vol.63, issue.5, pp.819-847, 1965.
DOI : 10.7326/0003-4819-63-5-819

J. Ramirez, Pulmonary alveolar proteinosis. Treatment by massive bronchopulmonary lavage, Archives of Internal Medicine, vol.119, issue.2, pp.147-56, 1967.
DOI : 10.1001/archinte.119.2.147

J. Ramirez, Alveolar proteinosis: Importance of pulmonary lavage, Am Rev Respir Dis, vol.103, pp.666-78, 1971.

J. Smith, J. Millen, P. Safar, and E. Robin, Intrathoracic Pressure, Pulmonary Vascular Pressures and Gas Exchange during Pulmonary Lavage, Anesthesiology, vol.33, issue.4, pp.401-406, 1970.
DOI : 10.1097/00000542-197010000-00007

P. Shah, D. Hansell, P. Lawson, K. Reid, and C. Morgan, Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis, Thorax, vol.55, issue.1, pp.67-77, 2000.
DOI : 10.1136/thorax.55.1.67

G. Michaud, C. Reddy, and A. Ernst, Whole-Lung Lavage for Pulmonary Alveolar Proteinosis, Chest, vol.136, issue.6, pp.1678-81, 2009.
DOI : 10.1378/chest.09-2295

M. Altose, R. Hicks, M. Edwards, and J. , Extracorporeal Membrane Oxygenation During Bronchopulmonary Lavage, Archives of Surgery, vol.111, issue.10, pp.1149-53, 1976.
DOI : 10.1001/archsurg.1976.01360280106017

H. Cai, S. Cui, J. L. Huang, Y. Cao, B. Wang et al., [pulmonary alveolar proteinosis treated with whole-lung lavage utilizing extracorporeal membrane oxygenation: A case report and review], Zhonghua Jie He He Hu Xi Za Zhi, vol.28, pp.242-246, 2005.

T. Centella, E. Oliva, I. Andrade, and A. Epeldegui, The use of a membrane oxygenator with extracorporeal circulation in bronchoalveolar lavage for alveolar proteinosis, Interactive CardioVascular and Thoracic Surgery, vol.4, issue.5, pp.447-456, 2005.
DOI : 10.1510/icvts.2005.110320

N. Hasan, S. Bagga, J. Monteagudo, H. Hirose, N. Cavarocchi et al., Extracorporeal Membrane Oxygenation to Support Whole-lung Lavage in Pulmonary Alveolar Proteinosis, Journal of Bronchology & Interventional Pulmonology, vol.20, issue.1, pp.41-45, 2013.
DOI : 10.1097/LBR.0b013e31827ccdb5

K. Kim, J. Kim, and Y. Kim, Use of extracorporeal membrane oxygenation (ECMO) during whole lung lavage in pulmonary alveolar proteinosis associated with lung cancer, European Journal of Cardio-Thoracic Surgery, vol.26, issue.5, pp.1050-1051, 2004.
DOI : 10.1016/j.ejcts.2004.08.005

A. Sihoe, V. Ng, R. Liu, and L. Cheng, Pulmonary Alveolar Proteinosis in Extremis: The Case for Aggressive Whole Lung Lavage with Extracorporeal Membrane Oxygenation Support, Heart, Lung and Circulation, vol.17, issue.1, pp.69-72, 2008.
DOI : 10.1016/j.hlc.2006.11.007

E. Sivitanidis, R. Tosson, A. Wiebalck, and A. Laczkovics, Combination of extracorporeal membrane oxygenation (ECMO) and pulmonary lavage in a patient with pulmonary alveolar proteinosis, European Journal of Cardio-Thoracic Surgery, vol.15, issue.3, pp.370-372, 1999.
DOI : 10.1016/S1010-7940(99)00013-5

W. Hammon, D. Mccaffree, and A. Cucchiara, A Comparison of Manual to Mechanical Chest Percussion for Clearance of Alveolar Material in Patients With Pulmonary Alveolar Proteinosis (Phospholipidosis), Chest, vol.103, issue.5, pp.1409-1421, 1993.
DOI : 10.1378/chest.103.5.1409

A. Perez and R. Rogers, Enhanced Alveolar Clearance With Chest Percussion Therapy and Positional Changes During Whole-Lung Lavage for Alveolar Proteinosis, Chest, vol.125, issue.6, pp.2351-2357, 2004.
DOI : 10.1378/chest.125.6.2351

F. Bonella, P. Bauer, M. Griese, T. Wessendorf, J. Guzman et al., Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis, European Respiratory Journal, vol.40, issue.6, pp.1468-74, 2012.
DOI : 10.1183/09031936.00017612

B. Brach, J. Harrell, and K. Moser, Alveolar Proteinosis, Chest, vol.69, issue.2, pp.224-231, 1976.
DOI : 10.1378/chest.69.2.224

S. Cheng, H. Chang, H. Lau, L. Lee, and P. Yang, Pulmonary Alveolar Proteinosis, Chest, vol.122, issue.4, pp.1480-1485, 2002.
DOI : 10.1378/chest.122.4.1480

M. Kavuru, E. Sullivan, R. Piccin, M. Thomassen, and J. Stoller, Exogenous Granulocyte???Macrophage Colony-Stimulating Factor Administration for Pulmonary Alveolar Proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.4, pp.1143-1151, 2000.
DOI : 10.1164/ajrccm.161.4.9906044

J. Seymour, J. Presneill, O. Schoch, G. Downie, P. Moore et al., Therapeutic Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Idiopathic Acquired Alveolar Proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.163, issue.2, pp.524-555, 2001.
DOI : 10.1164/ajrccm.163.2.2003146

S. Venkateshiah, T. Yan, T. Bonfield, M. Thomassen, M. Meziane et al., An Open-Label Trial of Granulocyte Macrophage Colony Stimulating Factor Therapy for Moderate Symptomatic Pulmonary Alveolar Proteinosis, Chest, vol.130, issue.1, pp.227-264, 2006.
DOI : 10.1378/chest.130.1.227

A. Khan, R. Agarwal, and A. Aggarwal, Effectiveness of Granulocyte-Macrophage Colony-Stimulating Factor Therapy in Autoimmune Pulmonary Alveolar Proteinosis, Chest, vol.141, issue.5, pp.1273-83, 2012.
DOI : 10.1378/chest.11-0951

M. Wylam, R. Ten, U. Prakash, H. Nadrous, M. Clawson et al., Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis, European Respiratory Journal, vol.27, issue.3, pp.585-93, 2006.
DOI : 10.1183/09031936.06.00058305

R. Tazawa and K. Nakata, Autoimmune pulmonary alveolar proteinosis and GM-CSF inhalation therapy, Folia Pharmacologica Japonica, vol.138, issue.2, pp.64-71, 2011.
DOI : 10.1254/fpj.138.64

R. Tazawa, Y. Inoue, T. Arai, T. Takada, Y. Kasahara et al., Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled gmcsf therapy, Chest, 2013.

R. Borie, M. Debray, C. Laine, M. Aubier, and B. Crestani, Rituximab therapy in autoimmune pulmonary alveolar proteinosis, European Respiratory Journal, vol.33, issue.6, pp.1503-1509, 2009.
DOI : 10.1183/09031936.00160908

A. Malur, M. Kavuru, I. Marshall, B. Barna, I. Huizar et al., Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis, Respiratory Research, vol.13, issue.1, p.46, 2012.
DOI : 10.1016/j.cmet.2005.01.002

A. Rubbert-roth, Assessing the safety of biologic agents in patients with rheumatoid arthritis, Rheumatology, vol.51, issue.suppl 5, pp.38-47, 2012.
DOI : 10.1093/rheumatology/kes114

K. Carson, D. Focosi, E. Major, M. Petrini, E. Richey et al., Monoclonal antibodyassociated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: A review from the research on adverse drug events and reports (radar) project. The lancet oncology, pp.816-840, 2009.

M. Kavuru, T. Bonfield, and M. Thomassen, Plasmapheresis, GM-CSF, and alveolar proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.7, pp.36-43, 1036.
DOI : 10.1164/ajrccm.167.7.950

M. Luisetti, G. Rodi, C. Perotti, I. Campo, F. Mariani et al., Plasmapheresis for treatment of pulmonary alveolar proteinosis, European Respiratory Journal, vol.33, issue.5, pp.1220-1222, 2009.
DOI : 10.1183/09031936.00097508

H. Reeves and J. Winters, The mechanisms of action of plasma exchange, British Journal of Haematology, vol.44, issue.3, pp.342-51, 2014.
DOI : 10.1111/bjh.12629

L. Parker and D. Novotny, Recurrent Alveolar Proteinosis Following Double Lung Transplantation, Chest, vol.111, issue.5, pp.1457-1465, 1997.
DOI : 10.1378/chest.111.5.1457

A. Gal, J. Bryan, K. Kanter, and E. Lawrence, Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation, The Journal of Heart and Lung Transplantation, vol.23, issue.1, pp.135-143, 2004.
DOI : 10.1016/S1053-2498(03)00032-9

S. Yousem, Alveolar lipoproteinosis in lung allograft recipients, Human Pathology, vol.28, issue.12, pp.1383-1389, 1997.
DOI : 10.1016/S0046-8177(97)90228-8

S. Patel, H. Sekiguchi, J. Reynolds, and M. Krowka, Pulmonary Alveolar Proteinosis, Canadian Respiratory Journal, vol.19, issue.4, pp.243-248, 2012.
DOI : 10.1155/2012/841530

H. Ishii, J. Seymour, R. Tazawa, Y. Inoue, N. Uchida et al., Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan, BMC Pulmonary Medicine, vol.87, issue.2, p.37, 2014.
DOI : 10.1111/j.1600-0609.2011.01653.x

H. Ishii, R. Tazawa, C. Kaneko, T. Saraya, Y. Inoue et al., Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan, European Respiratory Journal, vol.37, issue.2, pp.465-473, 2011.
DOI : 10.1183/09031936.00092910

H. Ishii, B. Trapnell, R. Tazawa, Y. Inoue, M. Akira et al., Comparative Study of High-Resolution CT Findings Between Autoimmune and Secondary Pulmonary Alveolar Proteinosis, Chest, vol.136, issue.5, pp.1348-55, 2009.
DOI : 10.1378/chest.09-0097

A. Nishida, A. Miyamoto, H. Yamamaoto, N. Uchida, K. Izutsu et al., Possible Association of Trisomy 8 with Secondary Pulmonary Alveolar Proteinosis in Myelodysplastic Syndrome, American Journal of Respiratory and Critical Care Medicine, vol.184, issue.2, pp.279-80, 2011.
DOI : 10.1164/ajrccm.184.2.279a

K. Cummings, W. Donat, D. Ettensohn, V. Roggli, P. Ingram et al., Pulmonary Alveolar Proteinosis in Workers at an Indium Processing Facility, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.5, pp.458-64, 2010.
DOI : 10.1164/rccm.200907-1022CR

K. Cummings, M. Nakano, K. Omae, K. Takeuchi, T. Chonan et al., Indium Lung Disease, Chest, vol.141, issue.6, pp.1512-1533, 2012.
DOI : 10.1378/chest.11-1880

K. Nagano, K. Gotoh, T. Kasai, S. Aiso, T. Nishizawa et al., Two- and 13-week Inhalation Toxicities of Indium-tin Oxide and Indium Oxide in Rats, Journal of Occupational Health, vol.53, issue.2, pp.51-63, 2011.
DOI : 10.1539/joh.L10128

K. Nagano, T. Nishizawa, Y. Eitaki, M. Ohnishi, T. Noguchi et al., Pulmonary Toxicity in Mice by 2- and 13-week Inhalation Exposures to Indium-tin Oxide and Indium Oxide Aerosols, Journal of Occupational Health, vol.53, issue.3, pp.234-243, 2011.
DOI : 10.1539/joh.10-0053-BR

D. Lison, J. Laloy, I. Corazzari, J. Muller, V. Rabolli et al., Sintered Indium-Tin-Oxide (ITO) Particles: A New Pneumotoxic Entity, Toxicological Sciences, vol.108, issue.2, pp.472-81, 2009.
DOI : 10.1093/toxsci/kfp014

C. Cordonnier, J. Fleury-feith, E. Escudier, K. Atassi, and J. Bernaudin, Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients., American Journal of Respiratory and Critical Care Medicine, vol.149, issue.3, pp.788-94, 1994.
DOI : 10.1164/ajrccm.149.3.8118651

A. Numata, E. Matsuishi, K. Koyanagi, S. Saito, Y. Miyamoto et al., Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia, American Journal of Hematology, vol.20, issue.2, pp.107-116, 2006.
DOI : 10.1002/ajh.20473

M. Sorror, M. Maris, R. Storb, F. Baron, B. Sandmaier et al., Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, vol.106, issue.8, pp.2912-2921, 2005.
DOI : 10.1182/blood-2005-05-2004

T. Suzuki, T. Sakagami, L. Young, B. Carey, R. Wood et al., Hereditary Pulmonary Alveolar Proteinosis, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.10, pp.1292-304, 2010.
DOI : 10.1164/rccm.201002-0271OC

G. Sebastio, M. Sperandeo, and A. G. , Lysinuric protein intolerance: Reviewing concepts on a multisystem disease, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.52, issue.1, pp.54-62, 2011.
DOI : 10.1002/ajmg.c.30287

A. Barilli, B. Rotoli, R. Visigalli, O. Bussolati, G. Gazzola et al., In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.32, 2010.
DOI : 10.1186/1750-1172-5-32

A. Hsu, E. Sampaio, J. Khan, K. Calvo, J. Lemieux et al., Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome, Blood, vol.118, issue.10, pp.2653-2658, 2011.
DOI : 10.1182/blood-2011-05-356352

M. Spinner, L. Sanchez, A. Hsu, P. Shaw, C. Zerbe et al., GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity, Blood, vol.123, issue.6, pp.809-830, 2014.
DOI : 10.1182/blood-2013-07-515528

J. Cuellar-rodriguez, J. Gea-banacloche, A. Freeman, A. Hsu, C. Zerbe et al., Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency, Blood, vol.118, issue.13, pp.3715-3735, 2011.
DOI : 10.1182/blood-2011-06-365049

R. Calado and N. Young, Telomere Diseases, New England Journal of Medicine, vol.361, issue.24, pp.2353-65, 2009.
DOI : 10.1056/NEJMra0903373

A. Khan and R. Agarwal, Pulmonary Alveolar Proteinosis, Respiratory Care, vol.56, issue.7, pp.1016-1044, 2011.
DOI : 10.4187/respcare.01125